IMPC (IMAGERIE MEDICALE PARIS CENTRE) acquired by QUALIUM
Context
Qualium Investissement is acquiring a 25% minority stake in IMPC from its associate radiologists. This primary LBO transaction follows a strategic period of reflection during which the founding doctors chose to maintain operational and capital control of their group rather than pursuing a majority sale. The operation is designed to provide the necessary capital to fund a targeted external growth strategy, particularly in the Paris region, while offering a medical-led alternative to the broader consolidation of the imaging market. A significant portion of the deal structure involves doubling the number of associates to integrate a new generation of radiologists into the group's governance. The transaction is supported by a senior debt facility that includes a substantial capital expenditure line for future acquisitions aimed at reinforcing the group's medical specialties. This partnership emphasizes long-term independence and professional excellence in a rapidly evolving regulatory and financial environment for medical practices.
IMPC (IMAGERIE MEDICALE PARIS CENTRE), which reported an EBITDA margin of in 2024, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (14.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
IMPC is a premier Parisian medical imaging group specializing in high-end diagnostics and interventional radiology. The organization operates through a network of 10 sites, including both private clinics and integrated centers within hospitals. The group is widely recognized for its technical leadership in 3 core medical domains: musculoskeletal imaging, women's health, and interventional procedures. Its reputation for excellence in sports medicine has led to prestigious partnerships with professional sports clubs and national athletic federations, including those for tennis and football, to provide specialized monitoring for elite athletes. Managed by a team of associate radiologists, the group manages over one hundred thousand patients annually, combining advanced technological equipment with specialized medical expertise to maintain its position as a leading independent player in the French healthcare landscape.
Ent. Value
Equity Value
Multiples
EV / Revenue
EV / EBITDA
EV / EBIT
Historical Financials (EUR)
Similar deals in Health Providers
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 11/2024 | GROUPE IMAGERIE CARDINET | RADIOLOGIE PARIS OUEST | FRANCE | Radiology |
| 11/2024 | WELLTOWER | CARE UK | UNITED KINGDOM | Nursing Homes |
| 10/2024 | ARDIAN | VISTA VISION | ITALY | Ophthalmology |
| 10/2024 | MONTEFIORE INVESTMENT | DEMENEGO | ITALY | Ophthalmology |
| 08/2024 | ORLANDO HEALTH | BROOKWOOD BAPTIST HEALTH SERVICES | UNITED STATES | Clinics / Hospitals |
| 06/2024 | INTEGRAL DIAGNOSTICS LIMITED | CAPITOL HEALTH LIMITED | AUSTRALIA | Radiology |
| 06/2024 | L-GAM / CAPZA / IDIA CAPITAL INVESTISSEMENT | PSV GROUP | FRANCE | Radiology |
| 01/2024 | ARDIAN / BPIFRANCE / MACSF | APRIUM PHARMACIE | FRANCE | Pharmacy |
| 12/2023 | ESSLING CAPITAL | X-RAY PHOCEA | FRANCE | Radiology |
| 12/2023 | ANDERA PARTNERS | GROUPE IMAGERIE CARDINET | FRANCE | Radiology |
REFERENCES
Valuation range: EV 50M - 150M EUR
Revenue range: 10M - 30M EUR
EBITDA range: 5M - 25M EUR
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of IMPC (IMAGERIE MEDICALE PARIS CENTRE) by QUALIUM are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Target: impc (imagerie medicale paris centre)
Acquirer: qualium